Haemonetics Corporation (HAE)
NYSE
Closed
Oct 8, 2026
Day's Range
111.6652 wk Range
48.17Overview - HAE - Haemonetics Corporation
Key Statistics
Valuation
Enterprise Value
5.71B
P/E (Trailing)
‪50.00‬
P/E (Forward)
‪17.91‬
PEG Ratio
‪17.36‬
Price / Sales (TTM)
‪3.48‬
Price / Book
‪5.62‬
EV / EBITDA
‪15.92‬
Profitability
Gross Margin
‪59.75%‬
Profit Margin
‪7.12%‬
Operating Margin
‪17.93%‬
Return on Assets
‪6.59%‬
Return on Equity
‪11.19%‬
Ownership
Shares Outstanding
45.47M
Float
44.88M
Short % of Shares Outstanding
‪8.81%‬
Held by Insiders
‪1.26%‬
Held by Institutions
‪112.43%‬
Price stats
Beta
‪0.60‬
50-Day Avg
‪99.40‬
200-Day Avg
‪75.14‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
11 analysts
Average price target
‪$ 108.40‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - HAE - Haemonetics Corporation
Peers - HAE - Haemonetics Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
- HAENYSEHaemonetics Corporation4.70BMarket Cap+52.41%52-week change50.01P/E (Trailing)‪7.12%‬Profit Margin
- CVXNYSEChevron Corporation406.24BMarket Cap+25.86%52-week change19.95P/E (Trailing)‪9.83%‬Profit Margin
- ABTNYSEAbbott Laboratories169.82BMarket Cap-37.17%52-week change31.55P/E (Trailing)‪11.64%‬Profit Margin
- MDTNYSEMedtronic plc110.49BMarket Cap-13.95%52-week change21.28P/E (Trailing)‪13.93%‬Profit Margin
- SYKNYSEStryker Corp.105.64BMarket Cap-32.98%52-week change28.32P/E (Trailing)‪14.43%‬Profit Margin
- ICENYSEIntercontinental Exchange, Inc.84.29BMarket Cap-5.93%52-week change21.39P/E (Trailing)‪38.24%‬Profit Margin
- BSXNYSEBoston Scientific Corp.61.73BMarket Cap-127.00%52-week change17.25P/E (Trailing)‪17.49%‬Profit Margin
Profile Summary - HAE - Haemonetics Corporation
About
Haemonetics Corporation is a global healthcare company dedicated to providing innovative blood management solutions for organizations around the world. The company plays a crucial role in the healthcare industry by offering devices and services that aim to improve the quality, efficiency, and safety of blood supply.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
